Plante Moran Financial Advisors, LLC Provention Bio, Inc. Transaction History

Plante Moran Financial Advisors, LLC

  • $1.17 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021
SELL
$11.79 - $18.94 $5,895 - $9,470
-500 Reduced 50.0%
500 $8,000
Q3 2020

Nov 12, 2020
BUY
$10.34 - $15.2 $5,170 - $7,600
500 Added 100.0%
1,000 $13,000
Q2 2020

Aug 10, 2020
SELL
$7.81 - $17.0 $113,245 - $246,500
-14,500 Reduced 96.67%
500 $7,000
Q1 2020

May 07, 2020
BUY
$5.42 - $17.75 $81,300 - $266,250
15,000 New
15,000 $138,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email